Provided by Tiger Trade Technology Pte. Ltd.

ResMed

228.42
+0.17000.07%
Post-market: 228.420.00000.00%19:30 EDT
Volume:1.09M
Turnover:247.21M
Market Cap:32.95B
PE:21.90
High:229.57
Open:228.25
Low:225.08
Close:228.25
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:0.98
T/O Rate:0.76%
Dividend:2.40
Dividend Rate:1.05%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.00
PE(LYR):21.90

Loading ...

RBC Capital Cuts ResMed Price Target to $276 From $321, Maintains Outperform Rating

MT Newswires Live
·
Jul 08

Resmed is Maintained at Equal-weight by Wells Fargo

Dow Jones
·
Jul 08

ResMed price target lowered to $225 from $227 at Wells Fargo

TIPRANKS
·
Jul 08

Deals of the Day-mergers and Acquisitions

Reuters
·
Jul 08

Resmed Inc : RBC Cuts Target Price to $276 from $321

THOMSON REUTERS
·
Jul 08

Resmed Bull Sees Divestment Sharpening Strategic Focus

Dow Jones
·
Jul 08

Resmed's Matrixcare Sale May Hint at AI Disruption Risk

Dow Jones
·
Jul 08

Resmed - Deal Valued at $490 Mln All-cash, Expected to Close in Q1 Fy2027 - SEC Filing

THOMSON REUTERS
·
Jul 08

Resmed - Reiterates Q4 Fy2026 Outlook for Net Interest Income and Share Repurchases - SEC Filing

THOMSON REUTERS
·
Jul 08

Resmed - Reiterates Fy2026 Outlook for Non-gaap Gross Margin, Sg&a, R&D, and Non-gaap Tax Rate - SEC Filing

THOMSON REUTERS
·
Jul 08

Resmed Sees 3Q Closing for Matrixcare Divestiture

Dow Jones
·
Jul 08

Frazier to acquire MatrixCare from ResMed, terms not disclosed

TIPRANKS
·
Jul 08

Resmed - Deal Includes Matrixcare, Healthcare First, Citus, and Home Health and Hospice Solutions

THOMSON REUTERS
·
Jul 08

Resmed - to Provide Financial Impact Updates in Q4 Fiscal Year 2026 Filings

THOMSON REUTERS
·
Jul 08

Resmed - to Sell Matrixcare Business to Frazier Healthcare Partners

THOMSON REUTERS
·
Jul 08

Resmed Announces Agreement to Sell MatrixCare Business

GlobeNewswire
·
Jul 08

ResMed offloads software business at massive discount

The West Australian
·
Jul 07

Movement Alert|ResMed Rises 5.01% in Regular Trading, Noctrix Health Acquisition Expands Sleep Portfolio Amid Earnings Anticipation

Market Focus
·
Jul 07

ResMed adjusts ASX CDI levels amid NYSE share activity

TIPRANKS
·
Jul 03

Statement of Cdis on Issue - Rmd-rmd.n

Reuters
·
Jul 03